A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.
Clinical trial NCT05686759 · RECRUITING
Trial details
- NCT number
- NCT05686759
- Sponsor
- GC Biopharma Corp
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-13
- Primary completion
- 2026-06-30
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.